HARNESSING THE POWER OF MICROGLIA TO TREAT BRAIN DISEASES

Loading...
Thumbnail Image
Degree type
PhD
Graduate group
Pharmacology
Discipline
Pharmacology, Toxicology and Environmental Health
Subject
CSF1R
HSCT
Macrophage
Microglia
Microglia replacement therapies
Neuroimmunology
Funder
Grant number
License
Copyright date
01/01/2025
Distributor
Related resources
Author
Lombroso, Sonia
Contributor
Abstract

Microglia (MG), the primary macrophage of the central nervous system, are highly specialized to meet the brains' functional demands. In health, MG maintain homeostasis by continuously surveying the brain parenchyma, detecting immune signaling, sensing ATP, influencing synapses, and responding to injury. Upon inflammation or injury, MG can become dysregulated and contribute to disease pathology. While the underlying mechanisms of MG dysregulation in many diseases are incompletely understood, even those we understand are difficult to treat due to limited ability to directly target MG. What if instead of trying to target each genetic component dysregulated in microglia, we could instead replace host microglia with healthy donor cells? This idea, termed microglia replacement therapy, involves depleting and subsequently replacing endogenous microglia with surrogate cells.In this dissertation, I discuss the pivotal roles microglia play in neurological diseases and encouraging data from new transplantation strategies that support the idea that targeting microglia is a promising strategy for cell-based interventions for neurological disorders. Next, I discuss the work I completed in my Ph.D. to develop more efficient and safer methods of microglia replacement therapies. With these projects, I addressed several roadblocks that previously limited the feasibility of microglia-based immunotherapies therapies. I created a high temporal resolution dataset detailing how microglia identity is programmed by the brain, I identified several targets involved in programming microglial identity that warrant further study, created tools to replace microglia in safe non-toxic manners, and I developed methods to deliver donor cells both intracranially and peripherally in a tissue-specific manner. In the final chapter, I discuss how ongoing and future studies might expand on these data. I hope that the findings discovered in my Ph.D. contribute to the expanding toolkit responsible for bringing microglia replacement therapies - and their transformative potential - closer to becoming a reality.

Advisor
Bennett, F., Chris
Date of degree
2025
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation